Overview
It is a one-arm open-label interventional study with transcranial direct current stimulation in an remote home-based setting with the aims to evaluate the feasibility (usability of the device, compliance of patients, usability of the teletherapy), the effectiveness (clinical ratings) and the compatability of this intervention in 20 patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Eligibility
Inclusion Criteria:
- ME/CFS diagnosis according to the Canadian Consensus Criteria
- residence near Regensburg and mother language German
- written informed consent
- stable medication if possible
Exclusion Criteria:
- contraindications for transcranial direct current stimulation
- certain neurological conditions as assessed by study physician
- participation in another study
- pregnancy and lactation period